Category Archives: U.S. Policy and Funding

Stalled funding, policies of 2018 pose continuing challenges to infectious disease responses ahead

By on .

A year that started with a shutdown of the U.S. government is ending the same way, demonstrating ongoing instability in American policy, funding and global health leadership. At the same time, from events dividing the ranks of global HIV responders, to the first Ebola outbreak fought in a war zone, the year has highlighted needs […]

Medical tourism brings antibiotic-resistant infections home

By on .

So many lessons are offered in a recent communication from the U.S. Centers for Disease Control and Prevention about antibiotic-resistant infections among patients returning to the U.S. after undergoing surgical procedures in Tijuana, Mexico. The CDC learned about the first of the carbapenem-resistant  infections at the end of September through its Antibiotic Resistance Laboratory Network. In […]

Vaccination before travel, support for global measles control needed to protect U.S. gains against the disease, study finds

By on .

A look at how measles comes into the United States highlights needs for both more vigilant vaccination efforts, and support for global efforts to eliminate the disease, according to a report in an upcoming Journal of Infectious Diseases. While measles was declared eliminated in the United States in 2000, over the years since then 553 […]

Measles report shows how setting reachable goals can guide progress, but not fast enough

By on .

The report on outcomes of measles elimination efforts released last week by the World Health Organization and the U.S. Centers for Disease Control and Prevention shows, as its title suggests, progress. Between the first year of this century and 2017, according to the report, Progress towards regional measles elimination, access to the first dose of […]